Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP71263.RA52gxSLvVcpM2ww5dkNJI7Ef7IythEDrolYLvY8nOYwI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP71263.RA52gxSLvVcpM2ww5dkNJI7Ef7IythEDrolYLvY8nOYwI130_assertion type Assertion NP71263.RA52gxSLvVcpM2ww5dkNJI7Ef7IythEDrolYLvY8nOYwI130_head.
- NP71263.RA52gxSLvVcpM2ww5dkNJI7Ef7IythEDrolYLvY8nOYwI130_assertion wasGeneratedBy ECO_0000203 NP71263.RA52gxSLvVcpM2ww5dkNJI7Ef7IythEDrolYLvY8nOYwI130_provenance.
- NP71263.RA52gxSLvVcpM2ww5dkNJI7Ef7IythEDrolYLvY8nOYwI130_assertion wasDerivedFrom gad-20130706 NP71263.RA52gxSLvVcpM2ww5dkNJI7Ef7IythEDrolYLvY8nOYwI130_provenance.
- NP71263.RA52gxSLvVcpM2ww5dkNJI7Ef7IythEDrolYLvY8nOYwI130_assertion SIO_000772 19450876 NP71263.RA52gxSLvVcpM2ww5dkNJI7Ef7IythEDrolYLvY8nOYwI130_provenance.
- NP71263.RA52gxSLvVcpM2ww5dkNJI7Ef7IythEDrolYLvY8nOYwI130_assertion evidence source_evidence_literature NP71263.RA52gxSLvVcpM2ww5dkNJI7Ef7IythEDrolYLvY8nOYwI130_provenance.
- NP71263.RA52gxSLvVcpM2ww5dkNJI7Ef7IythEDrolYLvY8nOYwI130_assertion description "[this study suggests that the activating KIR2DS4 may serve as CML susceptive gene to trigger leukemia development, while KIR2DS3 is possibly a protect gene of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP71263.RA52gxSLvVcpM2ww5dkNJI7Ef7IythEDrolYLvY8nOYwI130_provenance.